Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
News|Articles|October 1, 2005
Pharmaceutical Technology Europe
- Pharmaceutical Technology Europe-10-01-2005
- Volume 17
- Issue 10
Microfine polishing from I Holland
Author(s)Pharmaceutical Technology Editors
One of the world leaders in the manufacture of tablet compression tooling, I Holland, is offering a range of machines for the automatic polishing of tablet compression tooling.
Advertisement
One of the world leaders in the manufacture of tablet compression tooling, I Holland, is offering a range of machines for the automatic polishing of tablet compression tooling.
Using a simple yet effective process, tablet punches are loaded into specially designed fixtures and rotated through a compound of particles to achieve a microfine finish. Encased in stainless steel, the Pharma model offers the benefit of a fully enclosed operational area with a stainless steel hood to contain any dust particles, assisting with cGMP compliance.
I Holland offers microfine polishing.
The MF Polishers are ideal for use in the tool maintenance room and offer a range of benefits including consistent results every time on dull or discoloured punches; smoother operation and improved efficiency within the tablet press; reduced polishing man-hours; and a decreased risk of over-polishing. Available in two sizes, the MF35 holds up to 36 punches and the MF70 up to 60 punches. All MF polishers are available with easy touch-screen operation in various languages at no extra cost.
Articles in this issue
about 21 years ago
Stop, Look and Listenabout 21 years ago
Rapid Results for life Science Applicationsabout 21 years ago
Like-for-Like Exchangesabout 21 years ago
In-Process Control Methods for the Manufacture of APIsabout 21 years ago
E-learning system for Indiaabout 21 years ago
Tooling Preparation Practices and their Effect on Tablet Pickingabout 21 years ago
Organic Impurities in Chemical Drug Substancesabout 21 years ago
Pharmaceutical Dust Extraction and Vacuum CleaningAdvertisement
Related to this article
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Advertisement
Advertisement